The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $139.51

Today's change-0.02 -0.01%
Updated January 19 4:00 PM EST. Delayed by at least 15 minutes.
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $139.51

Today's change-0.02 -0.01%
Updated January 19 4:00 PM EST. Delayed by at least 15 minutes.

United Therapeutics Corp down slightly

United Therapeutics Corp closed down just (U.S.)$0.02 Friday to (U.S.)$139.51. Over the last five days, shares have lost 1.25% and 9.08% over the last 52 weeks. This security has underperformed the S&P 500 by 33.23% during the last year.

Key company metrics

  • Open(U.S.) $140.22
  • Previous close(U.S.) $139.53
  • High(U.S.) $141.05
  • Low(U.S.) $137.97
  • Bid / Ask(U.S.) $137.00 / (U.S.) $0.00
  • YTD % change-5.70%
  • Volume463,591
  • Average volume (10-day)440,154
  • Average volume (1-month)413,152
  • Average volume (3-month)413,893
  • 52-week range(U.S.) $112.01 to (U.S.) $169.89
  • Beta1.35
  • Trailing P/E12.30×
  • P/E 1 year forward10.89×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $11.34
Updated January 19 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.42%Sector:HealthcareIndustry:Biotechnology

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue446445371409
Total other revenue--------
Total revenue446445371409
Gross profit426426356381
Total cost of revenue20191428
Total operating expense125403107235
Selling / general / administrative476756140
Research & development55603667
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)3257----
Other operating expenses, total--------
Operating income32142264174
Interest income (expense), net non-operating-3-1-1-2
Gain (loss) on sale of assets------0
Other--------
Income before tax32144264172
Income after tax276-56179110
Income tax, total441008561
Net income276-56179110
Total adjustments to net income--------
Net income before extra. items276-56179110
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items276-56179110
Inc. avail. to common incl. extra. items276-56179110
Diluted net income276-56179110
Dilution adjustment--------
Diluted weighted average shares44454645
Diluted EPS excluding extraordinary itemsvalue per share6.27-1.253.892.43
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share6.332.473.892.43